271
Views
12
CrossRef citations to date
0
Altmetric
Review Article

Correlation of blood Cr(III) and adverse health effects: Application of PBPK modeling to determine non-toxic blood concentrations

, , &
Pages 618-637 | Received 16 Oct 2013, Accepted 18 May 2014, Published online: 28 Jul 2014

References

  • Abraham AS, Brooks BA, Eylath U. (1992). The effects of chromium supplementation on serum glucose and lipids in patients with and without non-insulin-dependent diabetes. Metabolism, 41, 768–71.
  • Al-Hamood MH, Elbetieha A, Bataineh H. (1998). Sexual maturation and fertility of male and female mice exposed prenatally and postnatally to trivalent and hexavalent chromium compounds. Reprod Fertil Dev, 10, 179–83.
  • Alimonti A, Bocca B, Mannella E, Petrucci F, Zennaro F, Cotichini R, et al. (2005). Assessment of reference values for selected elements in a healthy urban population. Ann Ist Super Sanita, 41, 181–7.
  • Amato P, Morales AJ, Yen SS. (2000). Effects of chromium picolinate supplementation on insulin sensitivity, serum lipids, and body composition in healthy, nonobese, older men and women. J Gerontol A Biol Sci Med Sci, 55, M260–3.
  • Anderson RA. (1986). Chromium metabolism and its role in disease processes in man. Clin Physiol Biochem, 4, 31–41.
  • Anderson RA. (1992). Chromium, glucose tolerance, and diabetes. Biol Trace Elem Res, 32, 19–24.
  • Anderson RA. (1998). Chromium, glucose intolerance and diabetes. J Am Coll Nutr, 17, 548–55.
  • Anderson RA, Bryden NA, Patterson KY, Veillon C, Andon MB, Moser-Veillon PB. (1993). Breast milk chromium and its association with chromium intake, chromium excretion, and serum chromium. Am J Clin Nutr, 57, 519–23.
  • Anderson RA, Bryden NA, Polansky MM. (1992). Dietary chromium intake: Freely chosen diets, institutional diet, and individual foods. Biol Trace Elem Res, 32, 117–21.
  • Anderson RA, Cheng N, Bryden NA, Polansky MM, Cheng N, Chi J, Feng J. (1997). Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes, 46, 1786–91.
  • Anderson RA, Kozlovsky AS. (1985). Chromium intake, absorption and excretion of subjects consuming self-selected diets. Am J Clin Nutr, 41, 1177–83.
  • Anderson RA, Polansky MM, Bryden NA, Bhathena SJ, Canary JJ. (1987). Effects of supplemental chromium on patients with symptoms of reactive hypoglycemia. Metabolism, 36, 351–5.
  • Anderson RA, Polansky MM, Bryden NA, Patterson KY, Veillon C, Glinsmann WH. (1983). Effects of chromium supplementation on urinary Cr excretion of human subjects and correlation of Cr excretion with selected clinical parameters. J Nutr, 113, 276–81.
  • Anderson RA, Polansky MM, Bryden NA, Roginski EE, Patterson KY, Reamer DC. (1982). Effect of exercise (running) on serum glucose, insulin, glucagon, and chromium excretion. Diabetes, 31, 212–6.
  • Ani M, Moshtaghie AA. (1992). The effect of chromium on parameters related to iron metabolism. Biol Trace Elem Res, 32, 57–64.
  • Antoniou J, Zukor DJ, Mwale F, Minarik W, Petit A, Huk OL. (2008). Metal ion levels in the blood of patients after hip resurfacing: A comparison between twenty-eight and thirty-six-millimeter-head metal-on-metal prostheses. J Bone Joint Surg Am, 90, 142–8.
  • Apel W, Stark D, Stark A, O’Hagan S, Ling J. (2013). Cobalt-chromium toxic retinopathy case study. Doc Ophthalmol, 126, 69–78.
  • ATSDR (Agency for Toxic Substances and Disease Registry). (2012). Toxicological Profile for Chromium. September 2012. Atlanta, GA: U.S. Department of Health and Human Services, Public Health Service, Agency for Toxic Substances and Disease Registry.
  • Bahijri SM, Alissa EM. (2011). Increased insulin resistance is associated with increased urinary excretion of chromium in non-diabetic, normotensive Saudi adults. J Clin Biochem Nutr, 49, 164–8.
  • Bailey RL, Gahche JJ, Lentino CV, Dwyer JT, Engel JS, Thomas PR, et al. (2011). Dietary supplement use in the United States, 2003–2006. J Nutr, 141, 261–6.
  • Bataineh H, Al-Hamood MH, Elbetieha A, Bani Hani I. (1997). Effect of long-term ingestion of chromium compounds on aggression, sex behavior and fertility in adult male rat. Drug Chem Toxicol, 20, 133–49.
  • Bataineh HN, Bataineh ZM, Daradka H. (2007). Short-term exposure of female rats to industrial metal salts: effect on implantation and pregnancy. Reprod Med Biol, 6, 179–83.
  • Behari J, Chandra SV, Tandon SK. (1978). Comparative toxicity of trivalent and hexavalent chromium to rabbits. III. Biochemical and histological changes in testicular tissue. Acta Biol Med Ger, 37, 463–8.
  • Belcher EH, Harriss EB. (1957). Studies of plasma volume, red cell volume and total blood volume in young growing rats. J. Physiol, 139, 74–8.
  • Biedermann KA, Landolph JR. (1990). Role of valence state and solubility of chromium compounds on induction of cytotoxicity, mutagenesis, and anchorage independence in diploid human fibroblasts. Cancer Res, 50, 7835–42.
  • Borel J, Majerus T, Polansky MM, Moser PB, Anderson RA. (1984). Chromium intake and urinary chromium excretion of trauma patients. Biol Trace Elem Res, 6, 317–26.
  • Boynton H, Evans GW. (1992). United States Patent 5,087,624. Chromic Picolinate Treatment. February 11, 1992.
  • Bozic KJ, Kurtz S, Lau E, Ong K, Chiu V, Vail TP, et al. (2009). The epidemiology of bearing surface usage in total hip arthroplasty in the United States. J Bone Joint Surg Am, 91, 1614–20.
  • Brown RO, Forloines-Lynn S, Cross RE, Heizer WD. (1986). Chromium deficiency after long-term total parenteral nutrition. Dig Dis Sci, 31, 661–4.
  • Buchman AL. (2006). Etiology and initial management of short bowel syndrome. Gastroenterology, 130, S5–15.
  • Campbell WW, Beard JL, Joseph LJ, Davey SL, Evans WJ. (1997). Chromium picolinate supplementation and resistive training by older men: Effects on iron-status and hematologic indexes. Am J Clin Nutr, 66, 944–9.
  • Campbell WW, Joseph LJO, Ostlund RE, Anderson PA, Farrell RA, Evans WJ. (2004). Resistive training and chromium picolinate: effects on inositols and liver and kidney functions in older adults. Int J Sport Nutr Exerc Metab, 14, 430–42.
  • Catalani S, Leone R, Rizzetti MC, Padovani A, Apostoli P. (2011). The role of albumin in human toxicology of cobalt: Contribution from a clinical case. ISRN Hematol, 2011, 1–6.
  • Catelas I, Campbell PA, Bobyn JD, Medley JB, Huk OL. (2006). Wear particles from metal-on-metal total hip replacements: Effects of implant design and implantation time. Proc Inst Mech l Eng Part H J Eng Med, 220, 195–208.
  • Cerulli J, Grabe DW, Gauthier I, Malone M, McGoldrick MD. (1998). Chromium picolinate toxicity. Ann Pharmacother, 32, 428–31.
  • Chen NS, Tsai A, Dyer IA. (1973). Effect of chelating agents on chromium absorption in rats. J Nutr, 103, 1182–6.
  • Coleman RF, Herrington J, Scales JT. (1973). Concentration of wear products in hair, blood, and urine after total hip replacement. Br Med J, 1, 527–9.
  • Das M, Misra MP, Kumar A, Kumar P, Ahmed S, Chandra SV. (1989). Chronic chromium poisoning with dermatitis in the leather industry. Contact Dermatitis, 20, 221–2.
  • Davignon J, Simmonds WJ, Ahrens EH. (1968). Usefulness of chromic oxide as an internal standard for balance studies in formula-fed patients and for assessment of colonic function. J Clin Invest, 47, 127–38.
  • De Flora S, Iltcheva M, Balansky RM. (2006). Oral chromium(VI) does not affect the frequency of micronuclei in hematopoietic cells of adult mice and of transplacentally exposed fetuses. Mutat Res, 610, 38–47.
  • De Pasquale D, Stea S, Squarzoni S, Bordini B, Amabile M, Catalani S, et al. (2013). Metal-on-metal hip prostheses: Correlation between debris in the synovial fluid and levels of cobalt and chromium ions in the bloodstream. Int Orthop, 38, 469–75.
  • Deshmukh NS, Bagchi M, Lau FC, Bagchi D. (2009). Safety of a novel oxygen-coordinated niacin-bound chromium(III) complex (NBC): I. Two-generation reproduction toxicity study. J Inorg Biochem, 103, 1748–54.
  • Doisy RJ, Streeten DHP, Levine RA, Chodos RB. (1969). Effects and metabolism of chromium in normals, elderly subjects, and diabetics. In: Hemphill DD, Ed. Trace Substances in Environmental Health - II. Proceedings of University of Missouri”s 2nd Annual Conference on Trace Substances in Environmental Health. Held at Memorial Union, University of Missouri - Columbia, Missouri: July 16, 17, and 18, 1968. Columbia: University of Missouri, pp. 75–82.
  • Doisy RJ, Streeten DHP, Souma ML, Kalafer ME, Rekant SI, Dalakos TG. (1971). Metabolism of 51chromium in human subjects normal, elderly, and diabetic subjects. In: Mertz W, Cornatzer WE, Eds. Newer Trace Elements in Nutrition, Chapter 8. New York: Marcel Dekker, , pp. 155–68.
  • Donaldson RM Jr, Barreras RF. (1966). Intestinal absorption of trace quantities of chromium. J Lab Clin Med, 68, 484–93.
  • Dowling HJ, Offenbacher EG, Pi-Sunyer FX. (1986). Abstract 1920. Chromium absorption in the vascularly perfused rat intestine. In: Federation of American Society for Experimental Biology, Eds. Federation of American Societies for Experimental Biology: 70th Annual Meeting, St. Louis, Missouri, April 13–18, 1986. Abstracts of Papers: 1–3378: Federation of American Society for Experimental Biology. 484.
  • Dowling HJ, Offenbacher EG, Pi-Sunyer FX. (1989). Absorption of inorganic, trivalent chromium from the vascularly perfused rat small intestine. J Nutr, 119, 1138–45.
  • Eaton DL, Gilbert SG. (2013). Principles of toxicology. In: Klaassen CD, Casarett LJ Doull J, Eds. Casarett and Doull's Toxicology: The Basic Science of Poisons, Chapter 2. New York: McGraw-Hill Education/Medical, pp. 13–48.
  • EGVM (Expert Group on Vitamins and Minerals). (2003). Safe Upper Levels for Vitamins and Minerals. London, UK: Food Standards Agency, pp.1–360.
  • Engh CA Jr, MacDonald SH, Sritulanondha S, Thompson A, Naudie D, Engh CA. (2009). Metal ion levels after metal-on-metal total hip arthroplasty: A randomized trial. Clin Orthop Relat Res, 467, 101–1.
  • Ferreira da Silva RA, Lopes RA, Sala MA, Vinha D, Regalo SCH, Maria de Souza AO, Gregorio ZMA. (2006). Action of trivalent chromium on rat liver structure. Histometric and hematological studies. Int. J. Morphol, 24, 197–203.
  • Fowler Jr JF. (2000). Systemic contact dermatitis caused by oral chromium picolinate. Cutis, 65, 116.
  • Freund H, Atamian S, Fischer JE. (1979). Chromium deficiency during total parenteral nutrition. JAMA, 241, 496–8.
  • Fritzsche J, Borisch C, Schaefer C. (2012). Case report: high chromium and cobalt levels in a pregnant patient with bilateral metal-on-metal hip arthroplasties. Clin Orthop, 470, 2325–31.
  • Gargas ML, Norton RL, Paustenbach DJ, Finley BL. (1994). Urinary excretion of chromium by humans following ingestion of chromium picolinate: Implications for biomonitoring. Drug Metab Dispos, 22, 522–9.
  • Ghosh D, Bhattacharya B, Mukherjee B, Manna B, Sinha M, Chowdhury J, Chowdhury S. (2002). Role of chromium supplementation in Indians with type 2 diabetes mellitus. J Nutr Biochem, 13, 690–7.
  • Gilbert CJ, Cheung A, Butany J, Zywiel MG, Syed K, McDonald M, et al. (2013). Hip pain and heart failure: The missing link. Can J Cardiol, [Online] Available at: http://www.sciencedirect.com/science/article/pii/S0828282X12014067. Accessed 8 January 2013.
  • Golubnitschaja O, Yeghiazaryan K. (2012). Opinion controversy to chromium picolinate therapy's safety and efficacy: ignoring ‘anecdotes’ of case reports or recognising individual risks and new guidelines urgency to introduce innovation by predictive diagnostics? EPMA J, 3, 11.
  • Greenwood NN, Earnshaw A. (1997). Chromium, molybdenum and tungsten. In: Greenwood NN, Earnshaw A, Eds. Chemistry of the Elements, Chapter 23. Boston: Butterworth-Heinemann pp. 1003–1039.
  • Grübl A, Marker M, Brodner W, Giurea A, Heinze G, Meisinger V, Zehetgruber H, Kotz R. (2007). Long-term follow-up of metal-on-metal total hip replacement. J Orthop Res, 25, 841–8.
  • Hahn CJ, Evans GW. (1975). Absorption of trace metals in the zinc-deficient rat. Am J Physiol, 228, 1020–3.
  • Hart AJ, Quinn PD, Sampson B, Sandison A, Atkinson KD, Skinner JA, et al. (2010). The chemical form of metallic debris in tissues surrounding metal-on-metal hips with unexplained failure. Acta Biomater, 6, 4439–46.
  • Hill CH. (1976). Mineral interrelationships. In: Prasad AS, Oberleas D, Eds. Trace Elements in Human Health and Disease. Volume II: Essential and Toxic Elements, Chapter 36. New York: Academic Press, pp. 281–300.
  • Hopkins Jr LL, Schwarz K. (1964). Chromium (III) binding to serum proteins, specifically siderophilin. Biochim Biophys Acta, 90, 484–91.
  • Horecker BL, Stotz E, Hogness TR. (1939). The promoting effect of aluminum, chromium, and the rare earths in the succinic dehydrogenase-cytochrome system. J Biol Chem, 128, 251–6.
  • Huszonek J. (1993). Over-the-counter chromium picolinate. Am J Psychiatry, 150, 1560–1.
  • IARC (International Agency for Research on Cancer). (1990). Chromium, Nickel and Welding. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Volume 49. Lyon: International Agency for Research on Cancer.
  • Ikeda T, Takahashi K, Kabata T, Sakagoshi D, Tomita K, Yamada M. (2010). Polyneuropathy caused by cobalt–chromium metallosis after total hip replacement. Muscle Nerve, 42, 140–3.
  • IOM (Institute for Medicine), Food and Nutrition Board (2001). Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Washington, DC: National Academic Press, pp.1–769.
  • Ivankovic S, Preussman R. (1975). Absence of toxic and carcinogenic effects after administration of high doses of chromic oxide pigment in subacute and long-term feeding experiments in rats. Food Cosmet Toxicol, 13, 347–51.
  • Jacobs JJ, Skipor AK, Doorn PF, Campbell P, Schmalzried TP, Black J, Amstutz HC. (1996). Cobalt and chromium concentrations in patients with metal on metal total hip replacements. Clin Orthop, S256–63.
  • Jain SK, Rains JL, Croad JL. (2007). Effect of chromium niacinate and chromium picolinate supplementation on lipid peroxidation, TNF-α, IL-6, CRP, glycated hemoglobin, triglycerides and cholesterol levels in blood of streptozotocin-treated diabetic rats. Free Radic Biol Med, 43, 1124–31.
  • Janicek P, Tomas T, Klepac L, Pelclová D, Sklenský M. (2012). Chronic intoxication with cobalt following revision total hip arthroplasty. Hip Intl. [Online] Available at: http://www.hip-int.com/article/chronic-intoxication-with-cobalt-following-revision-total-hip-arthroplasty. Accessed 1 November 2012.
  • Jeejeebhoy KN, Chu RC, Marliss EB, Greenberg GR, Bruce-Robertson A. (1977). Chromium deficiency, glucose intolerance, and neuropathy reversed by chromium supplementation, in a patient receiving long-term total parenteral nutrition. Am J Clin Nutr, 30, 531–8.
  • Kamboj VP, Kar AB. (1964). Antitesticular effect of metallic and rare earth salts. J Reprod Fertil, 7, 21–8.
  • Kasvosve I, Delanghe JR, Gomo ZA, Gangaidzo IT, Khumalo H, Wuyts B, et al. (2000). Transferrin polymorphism influences iron status in blacks. Clin Chem, 46, 1535–9.
  • Kirman CR, Aylward LL, Suh M, Harris MA, Thompson CM, Haws LC, et al. (2013). Physiologically based pharmacokinetic model for humans orally exposed to chromium. Chem Biol Interact, 204, 13–27.
  • Kirman CR, Hays SM, Aylward LL, Suh M, Harris MA, Thompson CM, et al. (2012). Physiologically based pharmacokinetic model for rats and mice orally exposed to chromium. Chem Biol Interact, 200, 45–64.
  • Kottwitz K, Laschinsky N, Fischer R, Nielsen P. (2009). Absorption, excretion and retention of 51Cr from labelled Cr-(III)-picolinate in rats. Biometals, 22, 289–95.
  • Kozlovsky AS, Moser PB, Reiser S, Anderson RA. (1986). Effects of diets high in simple sugars on urinary chromium losses. Metabolism, 35, 515–8.
  • Kreula MS. (1947). Absorption of carotene from carrots in man and the use of the quantitative chromic oxide indicator method in the absorption experiments. Biochem J, 41, 269–73.
  • Lanca S, Alves A, Vieira AI, Barata J, de Freitas J, de Carvalho A. (2002). Chromium-induced toxic hepatitis. Euro J Intern Med, 13, 518–20.
  • Leikin JB, Karydes HC, Whiteley PM, Wills BK, Cumpston KL, Jacobs JJ. (2013). Outpatient toxicology clinic experience of patients with hip implants. Clin Toxicol, 51, 230–6.
  • Leung FY, Galbraith LV. (1995). Elevated serum chromium in patients on total parenteral nutrition and the ionic species of contaminant chromium. Biol Trace Elem Res, 50, 221–8.
  • Lim TH, Sargent III T, Kusubov N. (1983). Kinetics of trace element chromium(III) in the human body. Am J Physiol, 244, R445–54.
  • Lovrincevic I, Leung FY, Alfieri MA, Grace DM. (1996). Can elevated chromium induce somatopsychic responses? Biol Trace Elem Res, 55, 163–71.
  • Lukaski HC, Siders WA, Penland JG. (2007). Chromium picolinate supplementation in women: effects on body weight, composition, and iron status. Nutrition, 23, 187–95.
  • MacDonald SJ, McCalden RW, Chess DG, Bourne RB, Rorabeck CH, Cleland D, Leung F. (2003). Metal-on-metal versus polyethylene in hip arthroplasty: a randomized clinical trial. Clin Orthop Relat Res, 282–96.
  • Mackenzie RD, Byerrum RU, Decker CF, Hoppert CA, Langham RF. (1958). Chronic toxicity studies. II. Hexavalent and trivalent chromium administered in drinking water to rats. AMA Arch Ind Health, 18, 232–4.
  • Mao X, Wong AA, Crawford RW. (2011). Cobalt toxicity—an emerging clinical problem in patients with metal-on-metal hip prostheses? Med J Aust, 194, 649–51.
  • Martin WR, Fuller RE. (1998). Suspected chromium picolinate-induced rhabdomyolysis. Pharmacotherapy, 18, 860–2.
  • McKinney TD. (1996). Tubulointerstitial diseases and toxic nephropathies. In: Cecil RL, Bennett JC, Plum F, Eds. Cecil Textbook of Medicine, Chapter 80. Philadelphia: Saunders, pp. 580–9.
  • Mennen B. (1997). Over-the-counter chromium and renal failure. Ann Intern Med, 127, 655–6.
  • Mertz W, Roginski EE, Reba RC. (1965). Biological activity and fate of trace quantities of intravenous chromium (III) in the rat. Am J Physiol, 209, 489–94.
  • MHRA (Medicines and Healthcare Products Regulatory Agency). (2012). Metal-on-Metal (MoM) Total Hip Replacements: MITCH TRH Acetabular Cups/MITCH TRH Modular Heads (Finsbury Orthopaedics) When Implanted with Uncemented Accolade Femoral Stems (Stryker Orthopaedics). London: MHRA.
  • Mita Y, Ishihara K, Fukuchi Y, Fukuya Y, Yasumoto K. (2005). Supplementation with chromium picolinate recovers renal Cr concentration and improves carbohydrate metabolism and renal function in type 2 diabetic mice. Biol Trace Elem Res, 105, 229–48.
  • Morris BW, Kouta S, Robinson R, MacNeil S, Heller S. (2000). Chromium supplementation improves insulin resistance in patients with Type 2 diabetes mellitus. Diabet Med, 17, 684–5.
  • Moukarzel A. (2009). Chromium in parenteral nutrition: Too little or too much? Gastroenterology, 137, S18–28.
  • Mozaffari MS, AbdelSayed R, Liu JY, Wimborne H, El-Remessy A, El-Marakby A. (2009). Effects of chromium picolinate on glycemic control and kidney of the obese Zucker rat. Nutr Meta, 6, 51.
  • Ng SK, Ebneter A, Gilhotra JS. (2013). Hip-implant related chorio-retinal cobalt toxicity. Indian J Ophthalmol, 61, 35–7.
  • Nielsen FH. (2007). Summary: The clinical and nutritional importance of chromium – Still debated after 50 years of research. In: Vincent JB, Ed. The Nutritional Biochemistry of Chromium (III), Chapter 13. Boston: Elsevier, pp. 265–76.
  • NRC (National Research Council). (1989). Chromium. In: National Research Council (NRC), Ed. Recommended Dietary Allowances, 10th Ed. Washington, DC: National Academy of Sciences, pp. 241–3.
  • NRC (National Research Council). (2002). Dietary reference intakes for vitamin A, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. A report of the panel on micronutrients and of interpretations and uses of dietary reference intakes, and the standing committee on the scientific evaluation of dietary reference intakes. National Research Council. Washington, DC: National Academy of Sciences.
  • NTP (National Toxicology Program). (2010). NTP Technical Report on the Toxicology and Carcinogenesis Studies of Chromium Picolinate Monohydrate (CAS no. 27882-76-4) in F344/N Rats and B6C3F1 Mice: (Feed Studies). NTP TR 556. NIH Publication No. 10-5897. June 2010. Research Triangle Park, NC: U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, National Toxicology Program.
  • Offenbacher EG. (1992). Chromium in the elderly. Biol Trace Elem Res, 32, 123–31.
  • Okada S, Suzuki M, Ohba H. (1983). Enhancement of ribonucleic acid synthesis by chromium(III) in mouse liver. J Inorg Biochem, 19, 95–103.
  • Oladut WK, Wang MM, Li YC, Stoecker BJ. (1985). Abstract 1988: Chromium and vanadium effects on adrenal ascorbate of guinea pigs. In: Federation of American Societies for Experimental Biology, Eds. Federation of American Societies for Experimental Biology, 69th Annual Meeting: Anaheim, California, April 21–26, 1985: Abstracts of Papers. Bethesda, MD: Federation of American Societies for Experimental Biology, pp. 751.
  • Oldenburg M, Wegner R, Baur X. (2009). Severe cobalt intoxication due to prosthesis wear in repeated total hip arthroplasty. J Arthroplasty, 24, 825.e15–20.
  • Olin KL, Stearns DM, Armstrong WH, Kearn CL. (1994). Comparative retention/absorption of 51 chromium (51Cr) from 51 Cr chloride, 51Cr nicotinate and 51Cr picolinate in a rat model. Trace Elem Electrolyt, 11, 182–6.
  • Onkelinx C. (1977). Compartment analysis of metabolism of chromium(III) in rats of various ages. Am J Physiol, 232, E478–84.
  • Pan TL, Wang PW, Chen CC, Fang JY, Sintupisut N. (2012). Functional proteomics reveals hepatotoxicity and the molecular mechanisms of different forms of chromium delivered by skin administration. Proteomics, 12, 477–89.
  • Paustenbach DJ, Galbraith DA, Finley BL. (2014). Interpreting cobalt blood concentrations in hip implant patients. Clin Toxicol, 52, 98–112.
  • Pazzaglia UE, Apostoli P, Congiu T, Catalani S, Marchese M, Zarattini G. (2011). Cobalt, chromium and molybdenum ions kinetics in the human body: Data gained from a total hip replacement with massive third body wear of the head and neuropathy by cobalt intoxication. Arch Orthop Trauma Surg, 131, 1299–1308.
  • Pelclova D, Sklensky M, Janicek P, Lach K. (2012). Severe cobalt intoxication following hip replacement revision: Clinical features and outcome. Clin Toxicol, 50, 262–5.
  • Perricone NV, Bagchi D, Echard B, Preuss HG. (2010). Long-term metabolic effects on different doses of niacin-bound chromium on Sprague-Dawley rats. Mol Cell Biochem, 338, 91–103.
  • Polyzois I, Nikolopoulos D, Michos I, Patsouris E, Theocharis S. (2012). Local and systemic toxicity of nanoscale debris particles in total hip arthroplasty. J Appl Toxicol, 32, 255–69.
  • Preuss HG, Echard B, Perricone NV, Bagchi D, Yasmin T, Stohs SJ. (2008). Comparing metabolic effects of six different commercial trivalent chromium compounds. J Inorg Biochem, 102, 1986–90.
  • Price Evans DA, Tariq M, Dafterdar R, Al Hussaini H, Sobki SH. (2009). Chromium chloride administration causes a substantial reduction of coronary lipid deposits, aortic lipid deposits, and serum cholesterol concentration in rabbits. Biol Trace Elem Res, 130, 262–72.
  • Ravina A, Slezack L. (1993). [Chromium in the treatment of clinical diabetes mellitus]. Harefuah, 125, 142–5, 191.
  • Ravina A, Slezak L, Mirsky N, Bryden NA, Anderson RA. (1999). Reversal of corticosteroid-induced diabetes mellitus with supplemental chromium. Diabet Med, 16, 164–7.
  • Riches AC, Sharp JG, Thomas DB, Smith SV. (1973). Blood volume determination in the mouse. J. Physiol, 228, 279–84.
  • Rizzetti MC, Liberini P, Zarattini G, Catalani S, Pazzaglia U, Apostoli P, Padovani A. (2009). Loss of sight and sound. Could it be the hip? Lancet, 373, 1052.
  • Sahin K, Tuzcu M, Orhan C, Agca CA, Sahin N, Guvenc M, et al. (2011). The effects of chromium complex and level on glucose metabolism and memory acquisition in rats fed high-fat diet. Biol Trace Elem Res, 143, 1018–30.
  • Sampson B, Hart A. (2012). Clinical usefulness of blood metal measurements to assess the failure of metal-on-metal hip implants. Ann Clin Biochem, 49, 118–31.
  • Sayato Y, Nakamuro K, Matsui S, Ando M. (1980). Metabolic fate of chromium compounds. I. Comparative behavior of chromium in rat administered with Na251CrO4 and 51CrCl3. J Pharmacobiodyn, 3, 17–23.
  • Schroeder HA, Balassa JJ, Tipton IH. (1962). Abnormal trace metals in man–chromium. J Chronic Dis, 15, 941–64.
  • Schwarz K, Mertz W. (1959). Chromium(III) and the glucose tolerance factor. Arch Biochem Biophys, 85, 292–5.
  • Seaborn CD, Stoecker BJ. (1989). Effects of starch, sucrose, fructose and glucose on chromium absorption and tissue concentrations in obese and lean mice. J Nutr, 119, 1444–51.
  • Shara M, Kincaid AE, Limpach AL, Sandstrom R, Barrett L, Norton N, et al. (2007). Long-term safety evaluation of a novel oxygen-coordinated niacin-bound chromium (III) complex. J Inorg Biochem, 101, 1059–69.
  • Shara M, Yasmin T, Kincaid AE, Limpach AL, Bartz J, Brenneman KA, et al. (2005). Safety and toxicological evaluation of a novel niacin-bound chromium (III) complex. J Inorg Biochem, 99, 2161–83.
  • Shinde UA, Goyal RK. (2003). Effect of chromium picolinate on histopathological alterations and STZ and neonatal STZ diabetic rats. J Cell Mol Med, 7, 322–29.
  • Sotos JG, Tower SS. (2013). Systemic disease after hip replacement: Aeromedical implications of arthroprosthetic cobaltism. Aviat Space Environ Med, 84, 242–5.
  • Sreejayan N, Marone PA, Lau FC, Yasmin T, Bagchi M, Bagchi D. (2010). Safety and toxicological evaluation of a novel chromium(III) dinicocysteinate complex. Toxicol Mech Methods, 20, 321–33.
  • Srivastava L, Jain VK, Kachru DN, Tandon SK. (1985). Comparative toxicity of trivalent and hexavalent chromium V: Enzymatic alterations in rat liver and kidneys. Ind Health, 23, 89–94.
  • Stallings D, Vincent JB. (2006). Chromium: A case study in how not to perform nutritional research. Curr Topics Nutraceut Res, 4, 89–112.
  • Staniek H, Krejpcio Z. (2009). The effects of tricentric chromium(III) propionate complex supplementation on pregnancy outcome and maternal and foetal mineral status in rat. Food Chem Toxicol, 47, 2673–78.
  • Steens W, Katzer A. (2008). Severe cobalt poisoning in endoprosthetic replacement of the hip. In: Collery P, Maymard I, Theophanides T, et al., Eds. Metal ions in Biology and Medicine. Volume 10. Proceedings of the 10th International Symposium on Metal Ions in Biology and Medicine Held in the Conference Hall of the Conseil General de Haute-Corse and of Polyclinique Maymard Bastia, Corsica, France, on May 19–22, 2008. Montrouge: J. Libbey, pp. 34–8.
  • Steens W, von Foerster G, Katzer A. (2006). Severe cobalt poisoning with loss of sight after ceramic-metal pairing in a hip–a case report. Acta Orthop, 77, 830–2.
  • Stickland LH. (1949). The activation of phosphoglucomutase by metal ions. Biochem J, 44, 190–7.
  • Stitch SR. (1957). Trace elements in human tissue. 1. A semi-quantitative spectrographic survey. Biochem J, 67, 97–103.
  • Tandon SK, Saxena DK, Gaur JS, Chandra SV. (1978). Comparative toxicity of trivalent and hexavalent chromium. Alterations in blood and liver. Environ Res, 15, 90–9.
  • Tokar EJ, Boyd WA, Freedman JH, Waalkes MP. 2013. Trivalent chromium. In: Klassen CD, Ed, Casarett and Doull's toxicology: The basic science of poisons, 8th edition. New York: McGraw Hill Medical, Chapter 23, pp. 1008.
  • Urberg M, Parent M, Mill D, Zemel M. (1986). Abstract 147. Evidence for synergism between chromium and nicotinic acid in normalizing glucose tolerance. Diabetes, 35 Suppl 1, 37A.
  • USEPA (United States Environmental Protection Agency). (1988). Recommendations for and Documentation of Biological Values for Use in Risk Assessment. EPA/600/6-87/008 (NTIS PB88179874). Washington, DC: US Environmental Protection Agency.
  • USEPA (United States Environmental Protection Agency). (1998). Chromium (III), insoluble salts (CASRN 16065–83-1). Retrieved on March 1 2013, from: http://www.epa.gov/iris/subst/0028.htm.
  • USEPA (United States Environmental Protection Agency). (2011). Exposure Factors Handbook 2011 Edition. EPA/600/R-09/052F September 2011. Washington, D.C.: U.S. Environmental Protection Agency, Office of Research and Development, National Center for Environmental Assessment.
  • USFDA (United States Food and Drug Administration). (2011). 21 CFR 101.9. Nutrition labeling of food. Revised April 1 2011: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm Accessed November 11, 2011.
  • Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M. (2006). Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact, 160, 1–40.
  • Vendittoli PA, Mottard S, Roy AG, Dupont C, Lavigne M. (2007). Chromium and cobalt ion release following the Durom high carbon content, forged metal-on-metal surface replacement of the hip. J Bone Joint Surg Br, 89, 441–8.
  • Vincent J. (1993). Low-molecular-weight chromium-binding substance and synthetic models. J Inorg Biochem, 51, 77.
  • Vincent JB. (1999). Mechanisms of chromium action: Low- molecular-weight chromium-binding substance. J Am Coll Nutr, 18, 6–12.
  • Vincent JB. (2000). Elucidating a biological role for chromium at a molecular level. Acc Chem Res, 33, 503–10.
  • Vincent JB. (2010). Chromium: celebrating 50 years as an essential element? Dalton Trans, 39, 3787–94.
  • Wallach S, Verch RL. (1986). Radiochromium distribution in aged rats. J Am Coll Nutr, 5, 291–8.
  • Wani S, Weskamp C, Marple J, Spry L. (2006). Acute tubular necrosis associated with chromium picolinate-containing dietary supplement. Ann Pharmacother, 40, 563–6.
  • Wasser WG, Feldman NS, D'Agati VD. (1997). Chronic renal failure after ingestion of over-the-counter chromium picolinate. Ann Intern Med, 126, 410.
  • Yamamoto A, Wada O, Manabe S. (1989). Evidence that chromium is an essential factor for biological activity of low-molecular-weight, chromium-binding substance. Biochem Biophys Res Commun, 163, 189–93.
  • Yamamoto A, Wada O, Ono T. (1981). A low-molecular-weight, chromium-binding substance in mammals. Toxicol Appl Pharmacol, 59, 515–23.
  • Yamamoto A, Wada O, Ono T. (1984). Distribution and chromium-binding capacity of a low-molecular-weight, chromium-binding substance in mice. J Inorg Biochem, 22, 91–102.
  • Yamamoto A, Wada O, Suzuki H. (1988). Purification and properties of biologically active chromium complex from bovine colostrum. J Nutr, 118, 39–45.
  • Yoshida M, Hatakeyama E, Hosomi R, Kanda S, Nishiyama T, Fukunaga K. (2010). Tissue accumulation and urinary excretion of chromium in rats fed diets containing graded levels of chromium chloride or chromium picolinate. J Toxicol Sci, 35, 485–91.
  • Young PC, Turiansky GW, Bonner MW, Benson PM. (1999). Acute generalized exanthematous pustulosis induced by chromium picolinate. J Am Acad Dermatol, 41, 820–3.
  • Zahid ZR, Al-Hakkak ZS, Kadhim AHH, Elias EA, Al-Jumaily IS. (1990). Comparative effects of trivalent and hexavalent chromium on spermatogenesis of the mouse. Toxicol Environ Chem, 25, 131–6.
  • Zywiel MG, Brandt JM, Overgaard CB, Cheung AC, Turgeon TR, Syed KA. (2013). Fatal cardiomyopathy after revision total hip replacement for fracture of a ceramic liner. Bone Joint J, 95, 31–7.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.